StockNews.com Begins Coverage on Athersys (NASDAQ:ATHX)

Stock analysts at StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX) in a report released on Friday. The firm set a “hold” rating on the biopharmaceutical company’s stock.

Athersys Stock Performance

Shares of ATHX stock opened at $0.00 on Friday. The firm has a market capitalization of $61,719.00, a price-to-earnings ratio of 0.00 and a beta of -0.90. Athersys has a 52 week low of $0.01 and a 52 week high of $1.99.

About Athersys

Athersys, Inc, a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions.